Dey Pharma to Offer EpiPen 2-Pak® and EpiPen Jr 2-Pak® Exclusively
Dey Pharma will exclusively offer the EpiPen® 2-Pak and EpiPen Jr 2-Pak (epinephrine) Auto-Injectors to encourage people to follow recommendations by the National Institute of Allergy and Infectious Diseases, which state that people at risk for or who have experienced anaphylaxis should have immediate access to two doses of epinephrine. More specifically, the guidelines indicate that if a person responds poorly to the initial dose or has ongoing or progressive symptoms despite initial dosing, repeated dosing may be required.
The EpiPen and EpiPen Jr Auto-Injectors (0.3 and 0.15 mg epinephrine) are used for the injection of epinephrine, the first-line treatment for allergic emergencies (anaphylaxis). EpiPen Auto-Injector is used to treat signs and symptoms of an allergic emergency, some of which include hives, redness of the skin, tightness in the throat, breathing problems and/or a decrease in blood pressure. Allergic emergencies can be caused by triggers such as food, stinging and biting insects, medicines, latex, or even exercise.
You never know when an allergic emergency will occur, so it’s essential to be prepared. Make sure you speak with your health care professional about how to identify the signs and symptoms of an allergic emergency. If you, your child or someone you're caring for shows signs or symptoms of an allergic emergency, inject the health care professional-prescribed EpiPen or EpiPen Jr. immediately, then promptly call 911 and seek immediate medical attention.
EpiPen and EpiPen Jr Auto-Injectors are available in single cartons and 2-Pak cartons. It is important that patients at risk for allergic emergencies carry two doses of epinephrine. EpiPen 2-Pak provides an additional dose if needed during an allergic emergency. More than two doses of EpiPen Auto-Injector should only be administered under direct medical supervision. Talk to your health care professional if you need additional EpiPen Auto-Injector 2-Paks to keep at work, school or other locations. Each EpiPen 2-Pak also includes a training device.
While there is no safety issue with the EpiPen and EpiPen Jr single package, Dey will transition away from distributing and marketing these in the United States.
This article was originally published in Coping® with Allergies & Asthma magazine, September/October 2011.